Lv1
34 积分 2026-07-01 加入
Subcutaneous Administration of Therapeutic Monoclonal Antibody Drug Products Using a Syringe in Blinded Clinical Trials: Advances and Key Aspects Related to Blinding/Matching/Masking Strategies for Placebo Formulation
7天前
已完结
Blinding approaches for large clinical trials involving sub-cutaneous administration of biologicals - a CMC perspective
14天前
已完结
Subcutaneous Administration of Therapeutic Monoclonal Antibody Drug Products Using a Syringe in Blinded Clinical Trials: Advances and Key Aspects Related to Blinding/Matching/Masking Strategies for Placebo Formulation
14天前
已完结
Abstract 5736: AZD9592: An EGFR-cMET bispecific antibody-drug conjugate (ADC) targeting key oncogenic drivers in non-small-cell lung cancer (NSCLC) and beyond
28天前
已完结
Discovery of INCA033989, a Monoclonal Antibody That Selectively Antagonizes Mutant Calreticulin Oncogenic Function in Myeloproliferative Neoplasms (MPNs)
1个月前
已关闭
Targeting calreticulin (CALR) in tumors: Cellular mechanisms, structural insights and ligand development advances
1个月前
已完结
皖公网安备34019202002308
